Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1300
0.00 (0.00%)
Jul 2, 2026, 4:00 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $600.71 thousand as of July 6, 2026. Its market cap has decreased by -90.53% in one year.
Market Cap
600.71K
Enterprise Value
-990.98K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 600.71K, a decrease of -97.78%. That is a compound annual growth rate of -65.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 600.71K | -27.78% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 861.05K |
| Agentix | 801.34K |
| Emmaus Life Sciences | 761.54K |
| Windtree Therapeutics | 717.56K |
| SQZ Biotechnologies Company | 707.79K |
| Halberd | 702.47K |
| Clearside Biomedical | 654.25K |
| CERo Therapeutics Holdings | 548.82K |